Sublingual Administration of Captopril in Patients with Acute Myocardial Ischemia

Clinical Cardiology

Volumn 14, Issue 6, 1991, Pages 463-468

  Haude, Michael ^a   Erbel, Raimund ^a   Steffen, Wolfgang ^a   Tschollar, Werner ^a   Meyer, Jürgen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

angiotensin converting enzyme inhibition; captopril; myocardial ischemia; sublingual administration.

Indexed keywords

CAPTOPRIL; GLYCERYL TRINITRATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION;

ACUTE DISEASE; ADMINISTRATION, SUBLINGUAL; ADULT; ANGINA PECTORIS; CAPTOPRIL; CLINICAL TRIALS; CORONARY DISEASE; CREATINE KINASE; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; MALE; MIDDLE AGE; NITROGLYCERIN;

EID: 0025910804     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.4960140628     Document Type: Article

References (26)

1. The role of vasodilator therapy in heart failure
2. Vasodilator therapy of cardiac failure
3. Acute and long‐term responses to an oral converting enzyme inhibitor, captopril, in congestive heart failure
4. Angiotensin converting enzyme inhibition in patients with congestive heart failure
5. Effect of captopril in heart failure
6. Improvement of chronic congestive heart failure by oral captopril
7. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin‐converting enzyme inhibitor
8. A placebo‐controlled trial of captopril in refractory chronic congestive heart failure
9. A cooperative, multicenter study of captopril in congestive heart failure: Hemodynamic effects and long‐term response
10. Clinical experience with blockade of the renin‐angiotensin‐aldosterone system by an oral converting enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients
11. Possible role of renin in hypertension as suggested by renin‐sodium profiling and inhibition of converting enzyme
12. Specific inhibition of the renin‐angiotensin system: A key to understanding blood pressure regulation
13. Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease
14. An angiotensin converting‐enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients
15. Design of specific inhibitors of angiotensin‐converting enzyme: New class of orally active antihypertensive agents
16. Coronary blood flow and ACE inhibition in coronary artery disease
17. Converting enzyme inhibition and coronary blood flow
18. Acute effects of captopril on the coronary circulation of patients with hypertension and angina
19. Tissue renin angiotensin systems: Focus on the heart
20. Circulating versus local renin‐angiotensin system in cardiovascular homeostasis
21. Identification and characterization of functional angiotensin II receptors on cultured heart myocytes
22. Comparison of sublingual captopril and nifedipine
23. Fast and safe blood pressure reduction from sublingual captopril (abstr)
24. Hämodynamik nach sublingualer Applikation von Captopril bei schwerer Herzinsuffizienz
25. Captopril enhances exercise performance in nitrate tolerant patients with angina pectoris (abstr)